Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Doruk, D. Celik, G. Yenisehirli, H. InonuKoseoglu, N. Bulut, O. Gunal, S. Celikel (Tokat, Turkey). The resistance rates of Acinetobacter baumannii at endotracheal aspirate cultures. Eur Respir J 2012; 40: Suppl. 56, 572

Member's Comments

No comment yet.

Related content which might interest you: Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults. Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017 Potential treatment for nosocomial respiratory strains of extreme drug resistant acinetobacter baumanii Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007 Activity of N-acetylcysteine in combination with colistin against a collection of colistin resistant Acinetobacter baumannii clinical isolates Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017 Direct LAMP assay from clinical sample for carbapenem resistant A. baumannii Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Antibiotic sensitivity of pseudomonas aeroginosa isolates of respiratory secretions taken from ICU patients of the NRITLD Source: Eur Respir J 2004; 24: Suppl. 48, 641s Year: 2004 Inhaled colistin on Acinetobacter baumannii treatment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Acinetobacter baumanii as a severity marker in a respiratory ICU Source: Eur Respir J 2006; 28: Suppl. 50, 786s Year: 2006 Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia Source: Eur Respir J 2007; 29: 548-560 Year: 2007 Synergistic activity of colistin in combination with N-acetylcysteine against colistin-resistant Acinetobacter Baumannii grown in biofilms Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Clinical  profile  and outcome of patients with sputum positive Acinetobacter baumanni infection Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Therapeutic intratracheal phage application against Acinetobacter baumannii lung infection in mice Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018 Comparative results of preemptive therapies in mechanically ventilated patients with carbapanem-resistant Acinetobacter baumannii (CRAB) Source: International Congress 2017 – Hospital-acquired infections: from prevention to treatment Year: 2017 Acinetobacter baumannii infection and colonization among pediatric patients in pediatric ICU and other ICUs Source: International Congress 2018 – Neonatology and paediatric intensive care Year: 2018 Clinical outcomes of tigecycline in the treatment of critically ill patients with multidrug-resistant Acinetobactor baumannii infection Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Association of acinetobacter baumannii respiratory isolates with hospital outcomes in ventilated patients Source: Eur Respir J 2006; 28: Suppl. 50, 785s Year: 2006 The role of efflux pump systems and OprD porine in antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients with bronchiectasis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Bacterial load and biofilm thickness of endotracheal tubes from ventilated piglets with MRSA pneumonia and antimicrobial treatment Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010 Prognosis of Acinetobacter baumannii bacteraemia in a respiratory ICU: 10 years‘ experience Source: Eur Respir J 2005; 26: Suppl. 49, 222s Year: 2005 Community-acquired pneumonia due to multidrug and non-multidrug resistant pseudomonas aeruginosa Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016